The mycotoxin Beauvericin exhibits immunostimulatory effects on dendritic cells via activating the TLR4 signaling pathway
X. Yang, S. Ali, M. Zhao, L. Richter, V. Schafer, J. S. Diecks, M. Frank, J. Qi, P. K. Larsen, J. Skerra, H. Islam, T. Wachtmeister, C. Alter, A. Huang, S. Bhatia, , S. Scheu
This study identifies Beauvericin as an activator of dendritic cells via the TLR4 signaling pathway, suggesting its potential as a vaccine adjuvant or cancer immunotherapy.
bioRxiv · Jan 20, 2022Immunology